(Dallas, TX. – October 7, 2011) StockGuru Shines its Spotlight on General Cannabis, Inc. (OTCBB: CANA) (OTCQX: CANA), a technology-based Internet marketing services company. Yesterday the Company announced its 21st consecutive monthly revenue gain for WeedMaps Media and provided a business update for its website SafeAccessMD. The Company closed on October 6, 2011, unchanged at $2.18, trading in a fifty-two week range of $4.90 – 1.50.
WeedMaps Media Delivers Continued Growth
WeedMaps Media, Inc. reported continued positive momentum, with its 21st consecutive month of revenue gains and a strong increase in revenue year-over-year. WeedMaps Media reported a more than threefold monthly revenue increase to $1,250,000 for the month of September 2011, compared to $365,177 for the month of September 2010.
The Company also reported continued increases in site traffic for both WeedMaps.com and WeedMaps smartphone applications. WeedMaps reported a year-over-year increase in website traffic of over 100% to more than 7 million page views for the month of September 2011, and over 9 million page views for WeedMaps smartphone applications for the same period. WeedMaps smartphone applications accounted for 58% of all visits to WeedMaps.com for the month of September.
“WeedMaps’ continuing growth validates our ability to generate significant revenue through Internet portals that serve niche markets, even as the current economy and overall market conditions remain volatile,” said Doug Francis, President of General Cannabis. “Clearly, our many offerings, including smartphone applications, offer winning solutions for those in the medical cannabis community. As a result of our successes, we strongly believe that we can leverage our technological platform and systems into other industry sectors.”
SafeAccessMD Progress Update
General Cannabis also reported the completion of beta testing for its website, SafeAccessMD, which provides patient management solutions and software applications to the alternative healthcare industry. With the completion of beta testing, SafeAccessMD is expanding its sales team to five professionals and is launching a national marketing campaign to drive membership and site traffic. SafeAccessMD will offer its patient management solutions and software applications to the general healthcare industry in addition to those in the field of cannabis medicine.
“We are excited about the commencement of our aggressive marketing campaign at SafeAccessMD,” said Jim Pakulis, CEO of General Cannabis. “With an estimated 30,000 general practitioners working in the states where medical cannabis is legal, we have a large target market of initial candidates for SafeAccessMD along with a massive pool of general medicine candidates that would benefit from our unmatched patient management solutions.”
“Compared with the average price of medical software applications of $750 to $800 per month, our SafeAccessMD solution — at monthly rates of only $299 — represents a 60% discount while offering superior functionality and benefits for medical practitioners.”
About General Cannabis
General Cannabis, Inc., a technology-based Internet marketing services company, offers customers an integrated suite of services including media, technology, marketing and information. Founded in 2010, General Cannabis is headquartered in Newport Beach, California. The Company’s common stock trades on the OTC market’s highest tier, OTCQX, under the ticker symbol “CANA.” www.GeneralCannabis.com
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). General Cannabis, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. General Cannabis, Inc. undertakes no obligation to revise these statements following the date of this news release.
To view this StockGuru Spotlight, please visit: http://stockguru.com/category/latest-spotlights/
To get free alerts on this and other similar stocks, please register here:
What is the StockGuru Spotlight?
Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worth of our readers’ attention.
StockGuru looks for potential break-out candidates in The StockGuru Spotlight. Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage. There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated Stockguru. Where that is the case, a proper disclosure is included below. StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.
To feature a company in The StockGuru Spotlight please contact the Publisher at [email protected]. If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile. Please contact the StockGuru Publisher John Pentony at this email address: [email protected].
Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. StockGuru is occasionally compensated for coverage. When this is the case, SG clearly indicates this with a disclosure of all compensation received in the past and present. Additionally SG also discloses any anticipated compensation in the future. Compensation is typically in cash. Sometimes a company pays SG in restricted shares. Pentony Enterprise and its associated companies does not take free trading shares for any reason at anytime. StockGuru is not a registered investment adviser or a broker-dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
John Pentony, Publisher, Stockguru.com
Tel: +1 469 252 3031
e-mail: [email protected]